Huarong Chen
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
Papers in
-
- Cancer-related molecular mechanisms research 17
- Oncology 23
- Cancer Immunotherapy and Biomarkers 8
Huarong Chen
97 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Cancer Research 1.2k
- Molecular Biology 2.2k
- Oncology 685
- Immunology 404
- Biochemistry 94
Countries citing papers authored by Huarong Chen
This map shows the geographic impact of Huarong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huarong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huarong Chen more than expected).
Fields of papers citing papers by Huarong Chen
This network shows the impact of papers produced by Huarong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huarong Chen. The network helps show where Huarong Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Huarong Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 8 | |
| 7 | 2023 | 7 | |
| 8 | Targeting m 6 A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer Hit paper breakdown → | 2023 | 154 |
| 9 | 2023 | 36 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 48 | |
| 12 | 2022 | 7 | |
| 13 | Upregulation of FTX Promotes Osteosarcoma Tumorigenesis by Increasing SOX4 Expression via miR-214-5p | 2020 | 1 |
| 14 | Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway | 2020 | 1 |
| 15 | 2019 | 34 | |
| 16 | 2019 | 39 | |
| 17 | 2019 | 44 | |
| 18 | 2017 | 51 | |
| 19 | Role of Squalene Epoxidase (SQLE) in promoting fatty liver disease-associated liver cancer | 2017 | 1 |
| 20 | 2012 | 38 |
About Huarong Chen
Huarong Chen is a scholar working on Cancer Research, Oncology, Immunology, Molecular Biology and Pathology and Forensic Medicine, having authored 103 papers that have together received 3.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (25 papers), Cancer-related molecular mechanisms research (17 papers), Cancer-related gene regulation (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Epigenetics and DNA Methylation (7 papers), Genetic factors in colorectal cancer (6 papers), interferon and immune responses (5 papers) and Endoplasmic Reticulum Stress and Disease (5 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (2.2k citations), Oncology (685 citations), Immunology (404 citations) and Biochemistry (94 citations). Huarong Chen has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Jun Yu, Chi Chun Wong, Wei Kang, Hongyan Gou, Weixin Liu, Joseph J.�Y. Sung, Dabin Liu, Yasi Pan, Jianning Zhai and Hao Su. Their work appears in journals such as Gastroenterology, Oncogene, Theranostics, Scientific Reports and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.